US5236917A
(en)
*
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
US5306818A
(en)
*
|
1990-11-01 |
1994-04-26 |
Sterling Winthrop Inc. |
Tetrahydro 2-saccharinylmerthyl aryl carboxylates
|
AU656027B2
(en)
*
|
1991-11-15 |
1995-01-19 |
Sanofi |
Saccharin derivative proteolytic enzime inhibitors
|
US5378720A
(en)
*
|
1991-12-19 |
1995-01-03 |
Sterling Winthrop Inc. |
Saccharin derivative proteolytic enzyme inhibitors
|
US5187173A
(en)
*
|
1991-12-27 |
1993-02-16 |
Sterling Winthrop Inc. |
2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
US5296496A
(en)
*
|
1991-12-27 |
1994-03-22 |
Sterling Winthrop Inc. |
2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
DE4427996A1
(de)
*
|
1994-08-08 |
1996-02-15 |
Basf Ag |
Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
|
US5750546A
(en)
*
|
1994-12-02 |
1998-05-12 |
Sanofi Winthrop, Inc. |
2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof
|
US5541168A
(en)
*
|
1994-12-02 |
1996-07-30 |
Sterling Winthrop Inc. |
Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
US5494925A
(en)
*
|
1994-12-02 |
1996-02-27 |
Sterling Winthrop Inc. |
2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
US5556909A
(en)
*
|
1994-12-02 |
1996-09-17 |
Sanofi Winthrop Inc. |
Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
|
US5512576A
(en)
*
|
1994-12-02 |
1996-04-30 |
Sterling Winthrop Inc. |
2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
DE19533643A1
(de)
*
|
1995-09-12 |
1997-03-13 |
Nycomed Arzneimittel Gmbh |
Neue cyclische Derivate von Benzolsulfonamiden
|
US5750550A
(en)
*
|
1995-09-15 |
1998-05-12 |
Sanofi |
2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof
|
US5670526A
(en)
*
|
1995-12-21 |
1997-09-23 |
Otsuka Pharmaceutical Co., Ltd. |
1,3,4-oxadiazoles
|
US5693354A
(en)
*
|
1996-05-01 |
1997-12-02 |
L'air Liquide, Societe Anonyme Pour L'etude Et, L'exploitation Des Procedes Georges Claude |
Method of disinfecting fresh vegetables by processing the same with a liquid containing a mixture of argon:carbon dioxide
|
US6420401B1
(en)
|
1997-08-22 |
2002-07-16 |
Wichita State University |
1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives
|
US6020358A
(en)
*
|
1998-10-30 |
2000-02-01 |
Celgene Corporation |
Substituted phenethylsulfones and method of reducing TNFα levels
|
AU2006200033B8
(en)
*
|
1998-10-30 |
2008-09-11 |
Celgene Corporation |
Substituted phenethylsulfones and methods of reducing TNF-alpha levels
|
BR0015532A
(pt)
|
1999-11-22 |
2002-06-25 |
Smithkline Beecham Plc |
Compostos
|
GB0005357D0
(en)
*
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
ES2218391T3
(es)
*
|
2000-03-06 |
2004-11-16 |
Smithkline Beecham Plc |
Derivados de imidazol como inhibidores de raf-cinasa.
|
AU8473301A
(en)
*
|
2000-08-08 |
2002-02-18 |
Ortho Mcneil Pharm Inc |
Non-imidazole aryloxyalkylamines
|
DE60112312T2
(de)
*
|
2000-09-21 |
2005-12-29 |
Smithkline Beecham P.L.C., Brentford |
Imidazolderivate als raf-kinase-inhibitoren
|
GB0112348D0
(en)
*
|
2001-05-19 |
2001-07-11 |
Smithkline Beecham Plc |
Compounds
|
WO2003000705A1
(en)
*
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel quinolines and uses thereof
|
WO2003022837A1
(en)
*
|
2001-09-05 |
2003-03-20 |
Smithkline Beecham P.L.C. |
Heterocycle-carboxamide derivatives as raf kinase inhibitors
|
US20050222175A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Dhanoa Dale S |
New piperidinylamino-thieno[2,3-D] pyrimidine compounds
|
US7612078B2
(en)
*
|
2003-03-31 |
2009-11-03 |
Epix Delaware, Inc. |
Piperidinylamino-thieno[2,3-D] pyrimidine compounds
|
WO2006051531A2
(en)
*
|
2004-11-09 |
2006-05-18 |
Spectrum Dynamics Llc |
Radioimaging
|
US7179827B2
(en)
*
|
2004-03-31 |
2007-02-20 |
Lexicon Genetics Incorporated |
Thiazoles and methods of their use
|
US7488736B2
(en)
*
|
2004-05-17 |
2009-02-10 |
Epix Delaware, Inc. |
Thienopyridinone compounds and methods of treatment
|
GB0420722D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
US7598265B2
(en)
*
|
2004-09-30 |
2009-10-06 |
Epix Delaware, Inc. |
Compositions and methods for treating CNS disorders
|
US7407966B2
(en)
*
|
2004-10-07 |
2008-08-05 |
Epix Delaware, Inc. |
Thienopyridinone compounds and methods of treatment
|
US7576211B2
(en)
|
2004-09-30 |
2009-08-18 |
Epix Delaware, Inc. |
Synthesis of thienopyridinone compounds and related intermediates
|
TWI462745B
(zh)
*
|
2005-04-28 |
2014-12-01 |
Takeda Pharmaceutical |
安定的乳化組成物
|
AU2006251989B2
(en)
*
|
2005-05-20 |
2010-05-27 |
Alantos-Pharmaceuticals, Inc. |
Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
|
US20070155738A1
(en)
*
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
US7579360B2
(en)
*
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US7572807B2
(en)
*
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
US7487406B2
(en)
*
|
2005-11-29 |
2009-02-03 |
International Business Machines Corporation |
Systems, methods, and media for managing software defects
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
US8492378B2
(en)
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
TW200817410A
(en)
*
|
2006-08-07 |
2008-04-16 |
Incyte Corp |
Triazolotriazines as kinase inhibitors
|
SI3034075T1
(sl)
*
|
2006-11-22 |
2018-12-31 |
Incyte Holdings Corporation |
Imidazotriazini in imidazopirimidini kot inhibitorji kinaze
|
TW200900065A
(en)
*
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
*
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
KR20100080597A
(ko)
*
|
2007-09-14 |
2010-07-09 |
오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 |
1,3-이치환된-4-페닐-1h-피리딘-2-온
|
NZ584152A
(en)
|
2007-09-14 |
2011-11-25 |
Ortho Mcneil Janssen Pharm |
1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
|
KR101520086B1
(ko)
*
|
2007-09-14 |
2015-05-14 |
얀센 파마슈티칼스 인코포레이티드 |
1´,3´-이치환된-4-페닐-3,4,5,6-테트라히드로-2h,1´h-[1,4´]비피리디닐-2´-온
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
JP5433582B2
(ja)
*
|
2007-11-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
イミダゾ[1,2−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
|
KR101706784B1
(ko)
|
2008-05-21 |
2017-02-14 |
인사이트 홀딩스 코포레이션 |
2-플루오로-N-메틸-4-[7-(퀴놀린-6-일-메틸)-이미다조[1,2-b][1,2,4]트리아진-2-일]벤즈아미드의 염 및 이의 제조 방법
|
CA2735764C
(en)
|
2008-09-02 |
2016-06-14 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
US8697689B2
(en)
|
2008-10-16 |
2014-04-15 |
Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
US8691813B2
(en)
|
2008-11-28 |
2014-04-08 |
Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
EP2445877B1
(en)
*
|
2008-12-03 |
2014-07-23 |
Nanotherapeutics, Inc. |
Bicyclic compounds and methods of making and using same
|
BRPI1012870B8
(pt)
|
2009-05-12 |
2021-05-25 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu uso como moduladores alostericos positivos de receptores de mglur2 e composição farmacêutica
|
EA020671B1
(ru)
|
2009-05-12 |
2014-12-30 |
Янссен Фармасьютикалз, Инк. |
ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
CN102812027B
(zh)
|
2010-02-03 |
2015-01-07 |
因西特公司 |
作为C-MET抑制剂的咪唑并[1,2-b][1,2,4]三嗪
|
US9012448B2
(en)
|
2010-11-08 |
2015-04-21 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
|
PT2649069E
(pt)
|
2010-11-08 |
2015-11-20 |
Janssen Pharmaceuticals Inc |
Derivados de 1,2,4-triazolo[4,3-a]piridina e sua utilização como moduladores alostéricos positivos de recetores mglur2
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
PL3738434T3
(pl)
|
2011-12-28 |
2024-03-04 |
Global Blood Therapeutics, Inc. |
Związki pośrednie do otrzymywania podstawionych związków benzaldehydowych i sposoby ich zastosowania do zwiększania natlenienia tkanek
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
KR20190041548A
(ko)
|
2013-03-15 |
2019-04-22 |
글로벌 블러드 테라퓨틱스, 인크. |
헤모글로빈 조정을 위한 화합물 및 이의 용도
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
CA2902711C
(en)
|
2013-03-15 |
2021-07-06 |
Global Blood Therapeutics, Inc. |
Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
CN105073728A
(zh)
|
2013-03-15 |
2015-11-18 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
KR102502485B1
(ko)
|
2014-01-21 |
2023-02-21 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
PE20160179A1
(es)
|
2014-02-07 |
2016-05-20 |
Global Blood Therapeutics Inc |
Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido
|
AU2015308350B2
(en)
|
2014-08-29 |
2020-03-05 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
TW201731509A
(zh)
|
2015-12-04 |
2017-09-16 |
全球血液治療公司 |
針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
WO2020072377A1
(en)
|
2018-10-01 |
2020-04-09 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
US11993580B1
(en)
|
2022-12-02 |
2024-05-28 |
Neumora Therapeutics, Inc. |
Methods of treating neurological disorders
|